ASCO 2026 Conference Review focus on Breast Cancer
In this review:
OPTIMA: test-directed therapy in ER+/HER2– early breast cancer
lidERA BC: results in pre/postmenopausal patients
SENOMAC: omission of complete axillary dissection after positive sentinel lymph node biopsy
AXSANA: predicting axillary response to neoadjuvant chemotherapy in node-positive breast cancer
Izalontamab brengitecan (iza-bren) in TNBC
SAKK 96/12 REDUSE: skeletal events with reduced denosumab dosing
ASCENT-03: PFS2 with SG vs. chemotherapy in TNBC
TROPION-Breast02: additional efficacy endpoints
OASIS-4: sleep & QoL with elinzanetant across endocrine therapy types
SERENA-6: camizestrant for emergent ESR1 alterations in advanced breast cancer
Expert contributor
Dr Nick Zdenkowski
Nick is a medical oncologist whose practice and research focusses on breast cancer. His clinical practice is based in Newcastle, NSW. He also works as Scientific Advisory Committee Chair and Medical Advisor for Breast Cancer Trials, based at the headquarters in Newcastle. His research interest is in neoadjuvant systemic therapy and shared decision-making for patients […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.